Research And Development Expense of NOVARTIS AG from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
NOVARTIS AG annual and quarterly Research And Development Expense in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • NOVARTIS AG Research And Development Expense for the quarter ending 30 Jun 2024 was $2,367,000,000, a 2.7% increase year-over-year.
  • NOVARTIS AG annual Research And Development Expense for 2024 was $10,022,000,000, a 12% decline from 2023.
  • NOVARTIS AG annual Research And Development Expense for 2023 was $11,371,000,000, a 24% increase from 2022.
  • NOVARTIS AG annual Research And Development Expense for 2022 was $9,172,000,000, a 6.1% increase from 2021.
Source SEC data
View on sec.gov
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Change (%)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Change (%)

NOVARTIS AG Annual Research And Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,022,000,000 -$1,349,000,000 -12% 01 Jan 2024 31 Dec 2024 20-F 31 Jan 2025 2024 FY
2023 $11,371,000,000 +$2,199,000,000 +24% 01 Jan 2023 31 Dec 2023 20-F 31 Jan 2025 2024 FY
2022 $9,172,000,000 +$531,000,000 +6.1% 01 Jan 2022 31 Dec 2022 20-F 31 Jan 2025 2024 FY
2021 $8,641,000,000 -$339,000,000 -3.8% 01 Jan 2021 31 Dec 2021 20-F 31 Jan 2024 2023 FY
2020 $8,980,000,000 -$422,000,000 -4.5% 01 Jan 2020 31 Dec 2020 20-F/A 15 May 2023 2022 FY
2019 $9,402,000,000 +$913,000,000 +11% 01 Jan 2019 31 Dec 2019 20-F 02 Feb 2022 2021 FY
2018 $8,489,000,000 +$100,000,000 +1.2% 01 Jan 2018 31 Dec 2018 20-F 26 Jan 2021 2020 FY
2017 $8,389,000,000 -$650,000,000 -7.2% 01 Jan 2017 31 Dec 2017 20-F 29 Jan 2020 2019 FY
2016 $9,039,000,000 +$104,000,000 +1.2% 01 Jan 2016 31 Dec 2016 20-F 30 Jan 2019 2018 FY
2015 $8,935,000,000 01 Jan 2015 31 Dec 2015 6-K 24 Jan 2018 2017 FY

NOVARTIS AG Quarterly Research And Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $2,367,000,000 +$63,000,000 +2.7% 01 Apr 2024 30 Jun 2024 6-K 18 Jul 2024 2024 Q2
Q2 2023 $2,304,000,000 -$194,000,000 -7.8% 01 Apr 2023 30 Jun 2023 6-K 18 Jul 2024 2024 Q2
Q2 2022 $2,498,000,000 +$98,000,000 +4.1% 01 Apr 2022 30 Jun 2022 6-K 18 Jul 2023 2023 Q2
Q2 2021 $2,400,000,000 -$41,000,000 -1.7% 01 Apr 2021 30 Jun 2021 6-K 19 Jul 2022 2022 Q2
Q2 2020 $2,441,000,000 +$390,000,000 +19% 01 Apr 2020 30 Jun 2020 6-K 21 Jul 2021 2021 Q2
Q2 2019 $2,051,000,000 -$75,000,000 -3.5% 01 Apr 2019 30 Jun 2019 6-K 21 Jul 2020 2020 Q2
Q2 2018 $2,126,000,000 +$64,000,000 +3.1% 01 Apr 2018 30 Jun 2018 6-K 18 Jul 2019 2019 Q2
Q2 2017 $2,062,000,000 01 Apr 2017 30 Jun 2017 6-K 18 Jul 2018 2018 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.